These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11012625)

  • 1. Humoral hyporesponsiveness to a conjugate contraceptive vaccine and its bypass by diverse carriers using permissible adjuvant.
    Mandokhot A; Pal R; Nagpal S; Chauhan VS; Ahlawat S; Singh O
    Clin Exp Immunol; 2000 Oct; 122(1):101-8. PubMed ID: 11012625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced immunogenicity of a contraceptive vaccine using diverse synthetic carriers with permissible adjuvant.
    Gupta A; Pal R; Ahlawat S; Bhatia P; Singh O
    Vaccine; 2001 May; 19(25-26):3384-9. PubMed ID: 11348702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier-induced epitope-specific regulation and its bypass in a protein-protein conjugate.
    Kaliyaperumal A; Chauhan VS; Talwar GP; Raghupathy R
    Eur J Immunol; 1995 Dec; 25(12):3375-80. PubMed ID: 8566026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG subclass distribution of anti-hCG and anti-diphtheria toxoid antibodies in women immunized with a beta-hCG based immunocontraceptive vaccine.
    Deshmukh US; Talwar GP; Gupta SK
    J Reprod Immunol; 1994 Jan; 26(1):65-72. PubMed ID: 7518875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
    BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
    Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior immunity to a carrier enhances antibody responses to hCG in recipients of an hCG-carrier conjugate vaccine.
    Shah S; Raghupathy R; Singh O; Talwar GP; Sodhi A
    Vaccine; 1999 Aug; 17(23-24):3116-23. PubMed ID: 10462248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune recognition of a molecule naturally presented as a monomeric or an oligomeric structure: the model of the human chorionic gonadotropin alpha subunit.
    Rouas N; Christophe S; Bellet D; Troalen F; Guillet JG; Bidart JM
    Mol Immunol; 1992; 29(7-8):883-93. PubMed ID: 1378932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of humoral immunity to the hCG beta protein antigen by fusing a molecular adjuvant C3d3.
    Wang XL; Li DJ; Yuan MM; Yu M; Yao XY
    J Reprod Immunol; 2004 Oct; 63(2):97-110. PubMed ID: 15380941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of synthetic peptides as immunogens for developing a vaccine against human chorionic gonadotropin.
    Stevens VC
    Ciba Found Symp; 1986; 119():200-25. PubMed ID: 2426053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carrier priming effect of CRM197 is related to an enhanced B and T cell activation in meningococcal serogroup A conjugate vaccination. Immunological comparison between CRM197 and diphtheria toxoid.
    Pecetta S; Tontini M; Faenzi E; Cioncada R; Proietti D; Seubert A; Nuti S; Berti F; Romano MR
    Vaccine; 2016 Apr; 34(20):2334-41. PubMed ID: 27015733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide vaccines derived from a malarial surface antigen: effects of dose and adjuvants on immunogenicity.
    Jones GL; Spencer L; Lord R; Mollard R; Pye D; Saul A
    Immunol Lett; 1990 Jul; 24(4):253-60. PubMed ID: 1697281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I clinical trial of a World Health Organisation birth control vaccine.
    Jones WR; Bradley J; Judd SJ; Denholm EH; Ing RM; Mueller UW; Powell J; Griffin PD; Stevens VC
    Lancet; 1988 Jun; 1(8598):1295-8. PubMed ID: 2453766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HSD-hCG vaccine prevents pregnancy in women: feasibility study of a reversible safe contraceptive vaccine.
    Talwar GP; Singh OM; Gupta SK; Hasnain SE; Pal R; Majumbar SS; Vrati S; Mukhopadhay A; Srinivasan J; Deshmukh U; Ganga S; Mandokhot A; Gupta A
    Am J Reprod Immunol; 1997 Feb; 37(2):153-60. PubMed ID: 9083611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The identification of peptide sequences of human chorionic gonadotropin containing a conformational epitope.
    Stevens VC; Chou WS; Powell JE; Lee AC; Smoot J
    Immunol Lett; 1986 Jan; 12(1):11-8. PubMed ID: 2420713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carrier priming with CRM 197 or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: biophysical and immunochemical interpretation.
    Pecetta S; Lo Surdo P; Tontini M; Proietti D; Zambonelli C; Bottomley MJ; Biagini M; Berti F; Costantino P; Romano MR;
    Vaccine; 2015 Jan; 33(2):314-20. PubMed ID: 25448110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contraceptive vaccines.
    Aitken RJ; Paterson M; Koothan PT
    Br Med Bull; 1993 Jan; 49(1):88-99. PubMed ID: 8324618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
    JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.
    Joshi MB; Gam AA; Boykins RA; Kumar S; Sacci J; Hoffman SL; Nakhasi HL; Kenney RT
    Infect Immun; 2001 Aug; 69(8):4884-90. PubMed ID: 11447164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potential anti-pregnancy vaccine built by conjugation of the beta-subunit of human chorionic gonadotropin to adjuvant-active muramyl peptide.
    Schutze MP; LeClerc C; Jolivet M; Deriaud E; Audibert F; Chang CC; Chedid L
    Am J Reprod Immunol Microbiol; 1987 Jul; 14(3):84-90. PubMed ID: 2445212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.